Stock ZNTL ZENTALIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Zentalis Pharmaceuticals, Inc.

Equities

ZNTL

US98943L1070

Market Closed - Nasdaq
Other stock markets
 01:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
4.2 USD -8.70% Intraday chart for Zentalis Pharmaceuticals, Inc. +1.45% -72.28%
20/06 UBS Downgrades Zentalis Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $5 From $28 MT
18/06 US Equity Markets Close Up Tuesday Following Less-Than-Expected Retail Sales Growth MT

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zentalis Pharmaceuticals, Inc. Announces Appointment of Luke Walker, M.D., to Board of Directors and Audit Committee of the Board
CI
Zentalis Pharmaceuticals, Inc. Announces Executive Changes
CI
Zentalis Pharmaceuticals Names Chief Medical Officer, Chief Business Officer
MT
Zentalis Pharmaceuticals, Inc. Announces Executive Changes
CI
Zentalis Pharmaceuticals Insider Bought Shares Worth $167,943, According to a Recent SEC Filing
MT
Zentalis Pharmaceuticals, Inc. Announces Executive Changes
CI
Zentalis Pharmaceuticals Chief Operating Officer to Depart
MT
Zentalis Pharmaceuticals Insider Sold Shares Worth $106,926, According to a Recent SEC Filing
MT
Zentalis Pharmaceuticals Insider Sold Shares Worth $118,355, According to a Recent SEC Filing
MT
Zentalis Pharmaceuticals, Inc. Announces Cease of Iris Roth as Chief Operating Officer, Effective October 10, 2023
CI
Zentalis Pharmaceuticals Insider Sold Shares Worth $125,238, According to a Recent SEC Filing
MT
Westport Fuel Systems Chief Executive Officer Resigns; Interim CEO Named; Down 1.8%
MT
Westport Fuel Systems Chief Executive Officer Resigns; Interim CEO Named
MT
Westport Fuel Systems Chief Executive David Johnson Resigns
MT
Westport Brief: Announcing Resignation of David Johnson, Chief Executive Officer, and Names Interim CEO
MT
Zentalis Pharmaceuticals, Inc. Appoints Kimberly Freeman as Chief Strategy Officer
CI
Insider Sell: Zentalis Pharmaceuticals
MT
Zentalis Pharmaceuticals, Inc. Appoints Diana Hausman to the Board of Directors
CI
Zentalis Pharmaceuticals Names Iris Roth Chief Operating Officer
MT
Zentalis Pharmaceuticals, Inc. Appoints Iris Roth as Chief Operating Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZNTL Stock
  4. News Zentalis Pharmaceuticals, Inc.
  5. Insiders